Viewing Study NCT01211002


Ignite Creation Date: 2025-12-25 @ 4:04 AM
Ignite Modification Date: 2026-06-16 @ 11:01 PM
Study NCT ID: NCT01211002
Status: UNKNOWN
Last Update Posted: 2010-09-29
First Post: 2010-09-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Concurrent Chemo-radiotherapy Combined With Recombinant Human Endostatin for Local Advanced Non-small Cell Lung Cancer (NSCLC)
Sponsor: Simcere Pharmaceutical Co., Ltd
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-small Cell Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Radiotherapy View
None rh-endostatin View
None chemotherapy View
None NSCLC View